Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rectal Neoplasms × Chemoradiotherapy, Adjuvant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Fluorouracil 267 Oxaliplatin 264 Capecitabine 222 Leucovorin 209 Irinotecan 151 Radiotherapy 130 Bevacizumab 111 Cetuximab 80 Folfox protocol 48 Surgical Procedures, Operative 43 Drug Therapy 41 Radiation 40 Neoadjuvant Therapy 40 Chemoradiotherapy 33 Chemotherapy, Adjuvant 32 Panitumumab 27 XELOX 25 Radiotherapy, Intensity-Modulated 21 Magnetic Resonance Spectroscopy 21 Floxuridine 17 Biopsy 16 Nivolumab 15 Gemcitabine 15 Early Intervention, Educational 15 pembrolizumab 14 Laparoscopy 14 IFL protocol 14 Celecoxib 14 trifluridine tipiracil drug combination 13 Gene Expression Profiling 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡